chronic graft versus host disease |
Disease ID | 796 |
---|---|
Disease | chronic graft versus host disease |
Definition | A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation. |
Synonym | chronc graft-vs-host dis chronic graft-versus-host disease chronic graft-versus-host disease (disorder) chronic gvhd graft versus host disease, chronic gvhd, chronic |
Orphanet | |
ICD10 | |
UMLS | C0867389 |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:9) C0037199 | sinusitis | 1 C0021843 | bowel obstruction | 1 C0023467 | acute myeloid leukemia | 1 C0314719 | dry eye | 1 C0020541 | portal hypertension | 1 C0013238 | dry eye syndrome | 1 C0023470 | myeloid leukemia | 1 C0023418 | leukemia | 1 C0020538 | hypertension | 1 |
Curated Gene | (Waiting for update.) |
Inferring Gene | Entrez_id | Symbol | Resource(Total Genes:2) |
Text Mined Gene | (Waiting for update.) |
Locus | (Waiting for update.) |
Disease ID | 796 |
---|---|
Disease | chronic graft versus host disease |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:8) HP:0000822 | Hypertension | 1 HP:0001909 | Leukemia | 1 HP:0000246 | Sinus inflammation | 1 HP:0012324 | Myeloid leukemia | 1 HP:0005214 | Bowel obstruction | 1 HP:0001409 | Portal hypertension | 1 HP:0004808 | Acute myelogenous leukemia | 1 HP:0000217 | Dry mouth syndrome | 1 |
Disease ID | 796 |
---|---|
Disease | chronic graft versus host disease |
Manually Symptom | UMLS | Name(Total Manually Symptoms:6) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:1) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:9) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs1131012 | 22646485 | 5175 | PECAM1 | umls:C0867389 | BeFree | We evaluated the association of 4 SNPs in ICAM1 (rs5498), PECAM1 (rs668 and rs1131012) and SELL (rs2229569) genes with acute and chronic graft-versus-host disease (GvHD) and those experiencing transplant-related mortality (TRM) within 1 year among 425 allogeneic HCT recipient-donor pairs. | 0.001085767 | 2013 | PECAM1 | 17 | 64350416 | T | C |
rs12428930 | 21628416 | 10673 | TNFSF13B | umls:C0867389 | BeFree | In multivariate analyses, 4 recipient BAFF SNPs (rs16972217 [odds ratio = 2.72, P = .004], rs7993590 [odds ratio = 2.35, P = .011], rs12428930 [odds ratio2.53, P = .008], and rs2893321 [odds ratio = 2.48, P = .009]) were independent predictors of GVHD subtypes, adjusted for conventional predictors of cGVHD. | 0.000542884 | 2011 | TNFSF13B;LOC102724347 | 13 | 108287357 | A | C |
rs16972217 | 21628416 | 10673 | TNFSF13B | umls:C0867389 | BeFree | In multivariate analyses, 4 recipient BAFF SNPs (rs16972217 [odds ratio = 2.72, P = .004], rs7993590 [odds ratio = 2.35, P = .011], rs12428930 [odds ratio2.53, P = .008], and rs2893321 [odds ratio = 2.48, P = .009]) were independent predictors of GVHD subtypes, adjusted for conventional predictors of cGVHD. | 0.000542884 | 2011 | TNFSF13B;LOC102724347 | 13 | 108283099 | C | T |
rs1805410 | 20574454 | 142 | PARP1 | umls:C0867389 | BeFree | One SNP in PARP1 gene (rs1805410) was associated with a higher risk of chronic GVHD (RR: 1.81, 95% CI: 1.29-2.54, P=0.001). | 0.000271442 | 2010 | PARP1 | 1 | 226380964 | T | C |
rs2229569 | 22646485 | 5175 | PECAM1 | umls:C0867389 | BeFree | We evaluated the association of 4 SNPs in ICAM1 (rs5498), PECAM1 (rs668 and rs1131012) and SELL (rs2229569) genes with acute and chronic graft-versus-host disease (GvHD) and those experiencing transplant-related mortality (TRM) within 1 year among 425 allogeneic HCT recipient-donor pairs. | 0.001085767 | 2013 | SELL | 1 | 169704697 | G | T,A |
rs2893321 | 21628416 | 10673 | TNFSF13B | umls:C0867389 | BeFree | In multivariate analyses, 4 recipient BAFF SNPs (rs16972217 [odds ratio = 2.72, P = .004], rs7993590 [odds ratio = 2.35, P = .011], rs12428930 [odds ratio2.53, P = .008], and rs2893321 [odds ratio = 2.48, P = .009]) were independent predictors of GVHD subtypes, adjusted for conventional predictors of cGVHD. | 0.000542884 | 2011 | TNFSF13B;LOC102724347 | 13 | 108290686 | A | G |
rs5498 | 22646485 | 5175 | PECAM1 | umls:C0867389 | BeFree | We evaluated the association of 4 SNPs in ICAM1 (rs5498), PECAM1 (rs668 and rs1131012) and SELL (rs2229569) genes with acute and chronic graft-versus-host disease (GvHD) and those experiencing transplant-related mortality (TRM) within 1 year among 425 allogeneic HCT recipient-donor pairs. | 0.001085767 | 2013 | ICAM1;ICAM4;LOC105372272 | 19 | 10285007 | A | G |
rs668 | 22646485 | 5175 | PECAM1 | umls:C0867389 | BeFree | We evaluated the association of 4 SNPs in ICAM1 (rs5498), PECAM1 (rs668 and rs1131012) and SELL (rs2229569) genes with acute and chronic graft-versus-host disease (GvHD) and those experiencing transplant-related mortality (TRM) within 1 year among 425 allogeneic HCT recipient-donor pairs. | 0.001085767 | 2013 | NA | NA | NA | NA | NA |
rs7993590 | 21628416 | 10673 | TNFSF13B | umls:C0867389 | BeFree | In multivariate analyses, 4 recipient BAFF SNPs (rs16972217 [odds ratio = 2.72, P = .004], rs7993590 [odds ratio = 2.35, P = .011], rs12428930 [odds ratio2.53, P = .008], and rs2893321 [odds ratio = 2.48, P = .009]) were independent predictors of GVHD subtypes, adjusted for conventional predictors of cGVHD. | 0.000542884 | 2011 | TNFSF13B;LOC102724347 | 13 | 108283554 | A | T |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |